Drug Profile
Research programme: antibody therapeutics - Amgen/Innovative Targeting Solutions
Alternative Names: HuTARG antibodies - Amgen/Innovative Targeting SolutionsLatest Information Update: 30 Oct 2019
Price :
$50
*
At a glance
- Originator Amgen; Innovative Targeting Solutions
- Class Antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified